INS and type 1 diabetes mellitus: In addition, the dominant T cell epitope, insulin B chain 9-23 (B9-23), was modified at the tyrosine 16 amino acid residue position to an alanine (Y16A) which is known to prevent activation of pathogenic Teff in NOD mice and human T1D subjects (36–38).